Canton Hathaway’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.09M Buy
2,273
+132
+6% +$134K 0.42% 32
2025
Q4
$2.3M Buy
2,141
+15
+0.7% +$14.3K 0.44% 30
2025
Q3
$1.62M Buy
2,126
+8
+0.4% +$5.95K 0.31% 41
2025
Q2
$1.65M Buy
2,118
+33
+2% +$25.6K 0.34% 38
2025
Q1
$1.72M Hold
2,085
0.35% 35
2024
Q4
$1.61M Hold
2,085
0.4% 33
2024
Q3
$1.85M Hold
2,085
0.46% 30
2024
Q2
$1.89M Hold
2,085
0.52% 28
2024
Q1
$1.62M Sell
2,085
-60
-3% -$42.7K 0.44% 32
2023
Q4
$1.25M Hold
2,145
0.38% 33
2023
Q3
$1.15M Hold
2,145
0.36% 33
2023
Q2
$1.01M Hold
2,145
0.31% 38
2023
Q1
$737K Hold
2,145
0.25% 44
2022
Q4
$785K Hold
2,145
0.27% 42
2022
Q3
$694K Hold
2,145
0.25% 46
2022
Q2
$695K Hold
2,145
0.24% 53
2022
Q1
$614K Buy
2,145
+460
+27% +$118K 0.17% 67
2021
Q4
$465K Buy
1,685
+1,000
+146% +$254K 0.13% 83
2021
Q3
$158K Buy
685
+185
+37% +$45.7K 0.05% 122
2021
Q2
$115K Hold
500
0.03% 127
2021
Q1
$93K Hold
500
0.03% 135
2020
Q4
$84K Hold
500
0.03% 145
2020
Q3
$74K Hold
500
0.03% 192
2020
Q2
$82K Hold
500
0.05% 93
2020
Q1
$69K Hold
500
0.05% 89
2019
Q4
$66K Hold
500
0.03% 114
2019
Q3
$56K Buy
500
+470
+1,567% +$52.3K 0.03% 114
2019
Q2
$3K Buy
+30
New +$3.53K ﹤0.01% 243

Other funds holding LLY

Canton Hathaway's LLY Position: Q1 2026 in Review

Canton Hathaway increased its Eli Lilly (LLY) stake by 6.2% in Q1 2026, buying an estimated $134K and bringing the position to 2,273 shares worth $2.09M. The position accounts for 0.42% of the portfolio, ranked #32.

Canton Hathaway first reported a position in LLY in Q2 2019 and has held it in 28 quarters since. The position peaked at $2.3M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Canton Hathaway held 2,273 shares of Eli Lilly worth $2.09M as of Q1 2026.
  • Canton Hathaway bought 132 Eli Lilly shares in Q1 2026, an estimated $134K.
  • Eli Lilly made up 0.42% of Canton Hathaway's portfolio in Q1 2026, its #32 holding.
  • Canton Hathaway first reported a position in Eli Lilly in Q2 2019 and has held it in 28 quarters since.
  • Canton Hathaway's Eli Lilly position peaked at $2.3M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Canton Hathaway's 13F filing for Q1 2026, filed 24 Apr 2026.